About Farger
Empathy and care being the cornerstone of our belief, Farger aims to deliver the global quality of medicines at affordable prices. To create delight for our customer, pride for our employees and trust as a synonym of our brand. This is our motto. This is all About Farger.
Vision
At Farger, our vision is to be among the Most Trusted and Respected Pharmaceutical companies globally
Mission
Develop and manufacture high quality products to strengthen health care. To make Farger the most trusted brand in healthcare
To create economic growth and societal value for the local community. Expand business operations to deliver high quality products and services to our consumers
Why Choose Farger?
INTEGRITY
To maintain the highest ethical standard in our business conduct. Act with honesty towards our consumers, partners and other stakeholders
QUALITY
We are committed to producing the highest quality products and services for our customers. We provide safe and effective products to our customers.
INNOVATION
Excellence with continuous improvement and constant innovation. We stay up to date with the latest technology and practices in Pharma Industry.
VALUE TO CUSTOMER
We are committed to providing cost effective and economical products and services to our customers and partners. We build lasting relationship with our stakeholder for long term growth.
EMPATHY
We help our surrounding communities thrive by empathizing and understanding their medical needs. An empathy driven culture helps create a responsible business.
SUSTAINABILITY
Effective, efficient and justified use of available resources. Enable growth through effective resource allocation to help protect our communities and planet earth from the ravages of climate change.
Partner with Farger
Each partnership with Farger is unique and built around shared priorities that contribute towards our goal of delivering global quality medicines at affordable prices. The profitability and growth in our delivery framework is what makes out partner programs the most preferred vis-a-vis other pharma companies.
